Global Animal Testing And Non-Animal Alternative Testing Market Size, Growth, Drivers, Restraints, Opportunity and Forecast To 2035

Animal Testing And Non-Animal Alternative Testing Market - By Type (Animal Type, Industrial Application), Drivers, Restraints, Global Opportunities And Strategies – Global Forecast To 2035 By The Business Research Company

The global animal testing market was valued at $10.74 billion in 2019and the market is expected to grow at a compound annual growth rate (CAGR) of 4.27% during 2019-2025 and at a CAGR of 2.46% during 2025-2035.

The global non-animal alternative testing market was valued at $1.11 billion in 2019. The market is expected to grow at a CAGR of 10.40% during 2019-2025 and at a CAGR of 11.62% during 2025-2035.

The key drivers of the animal testing market include:
The Need For Preclinical Studies For The Approval Of Therapeutics:
The need for preclinical studies is on the rise as the researchers gain insights on new drug candidates’ dosing and toxicity while conducting these studies in animal models. Preclinical studies provide information about the safety and efficacy of a drug candidate before testing it in humans. The studies require appropriate preclinical models that are comparable to the target population to ensure reliable results.

The key drivers of the non-animal alternative testing market include:
Ethical Concerns On Animal Experimentations
Alternative animal testing technologies are increasingly adopted by the end-use industries due to the pressure from animal rights organizations such as PETA, and Cruelty-Free International to treat animals in an ethical way. These animal rights organizations are protesting and conducting media campaigns in order to stop animal physiological distress and suffering for research on drugs, cosmetic products, chemicals, and food ingredients. These organizations are working closely with government agencies, educational institutions, and end-use industries to provide funding for developing alternative technologies. Therefore, ethical concerns on animal experiments are creating new legislation in various countries thereby driving the alternative technologies market.

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/animal-testing-and-non-animal-alternative-testing-market

Animal Testing And Non-Animal Testing Market Segmentation:
The animal testing market is segmented by type of end use industrial application, and by geography.
By End-Use - The animal market can be segmented by end-use industrial application into
a) Pharmaceuticals
b) Academic Research
c) Medical Devices
d) Chemicals & Pesticides
e) Cosmetics
f) Others

By Geography - The animal testing market is segmented into
o USA
o Japan
o China
o Australia
o France
o Canada
o UK
o Germany

Request For A Sample Copy Of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2755&type=smp

By Geography - The non-animal alternative testing market is segmented into
o USA
o Japan
o Europe
o ROW

Some of the major key players involved in the animal testing and non-animal alternative testing market are
• Emulate, Inc
• Organovo Holdings, Inc
• MatTek Corporation
• EMD Millipore
• China Tissue Engineering Co., Ltd. (J-TEC)
• ReproCell Inc
• Organ Technologies Co, Ltd
• Episkin

Place a DIRECT PURCHASE ORDER of entire 280+ pages report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2755

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.